A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
Clinical trial NCT05533801 · COMPLETED
Trial details
- NCT number
- NCT05533801
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-06
- Primary completion
- 2023-01-06
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.